Warning: The NCBI web site requires JavaScript to function. more...
HLA-B27: natural function and pathogenic role in spondyloarthritis.
McMichael A, Bowness P.
Arthritis Res. 2002;4 Suppl 3:S153-8. Epub 2002 May 9. Review.
Related citations
HLA B27 in health and disease: a double-edged sword?
Bowness P.
Rheumatology (Oxford). 2002 Aug;41(8):857-68. Review.
Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.
Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P.
Eur J Immunol. 2003 Mar;33(3):748-59.
The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.
Kollnberger S, Bowness P.
Adv Exp Med Biol. 2009;649:277-85. Review.
The role of HLA-B27 in spondyloarthritis.
Allen RL, Bowness P, McMichael A.
Immunogenetics. 1999 Nov;50(3-4):220-7. Review.
Taurog JD.
J Rheumatol. 2010 Dec;37(12):2606-16.
HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, Breban M, McMichael AJ, Bowness P.
J Immunol. 2004 Aug 1;173(3):1699-710.
Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, McMichael A, Bowness P.
Eur J Immunol. 2007 May;37(5):1313-22.
Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.
Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, Bowness P.
Arthritis Rheum. 2002 Nov;46(11):2972-82.
Allospecific T cell epitope sharing reveals extensive conservation of the antigenic features of peptide ligands among HLA-B27 subtypes differentially associated with spondyloarthritis.
Montserrat V, Martí M, López de Castro JA.
J Immunol. 2003 Jun 1;170(11):5778-85.
Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies.
Gaston H.
Nat Clin Pract Rheumatol. 2006 Jul;2(7):383-92. Review.
Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors.
Allen RL, Trowsdale J.
Curr Mol Med. 2004 Feb;4(1):59-65. Review.
From HLA-B27 to spondyloarthritis: a journey through the ER.
Colbert RA, DeLay ML, Klenk EI, Layh-Schmitt G.
Immunol Rev. 2010 Jan;233(1):181-202. Review.
HLA-B27: portraying immunodominant viral epitopes.
López de Castro JA.
Eur J Immunol. 2005 Feb;35(2):336-40.
HLA-B27: a registry of constitutive peptide ligands.
Lopez de Castro JA, Alvarez I, Marcilla M, Paradela A, Ramos M, Sesma L, Vázquez M.
Tissue Antigens. 2004 May;63(5):424-45.
HLA-B27 and disease pathogenesis: new structural and functional insights.
Bowness P, Zaccai N, Bird L, Jones EY.
Expert Rev Mol Med. 1999 Oct 26;1999:1-10.
The HLA-B*2705 peptidome.
Ben Dror L, Barnea E, Beer I, Mann M, Admon A.
Arthritis Rheum. 2010 Feb;62(2):420-9.
Bacteria-specific cytotoxic CD8+ T cells: a missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies.
Hermann E, Fleischer B, Meyer zum Büschenfelde KH.
Ann Med. 1994 Oct;26(5):365-9. Review.
Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB.
J Exp Med. 1993 Sep 1;178(3):879-87.
Dendritic cell: T-cell interactions in spondyloarthritis.
Gaston JS, Jarvis LB, Zhang L, Goodall JC.
Adv Exp Med Biol. 2009;649:263-76. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on